Circulating Levels of Secretory Type II Phospholipase A 2 Predict Coronary Events in Patients with Coronary Artery Disease
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background —The circulating levels of secretory nonpancreatic type II phospholipase A 2 (sPLA 2 ) are increased in various chronic inflammatory diseases and the increase in the levels correlates with the disease severity. sPLA 2 may possibly play a role in atherogenesis and is highly expressed in atherosclerotic arterial walls that are known to have inflammatory features. Thus, this study prospectively examined whether circulating levels of sPLA 2 may have a significant risk and prognostic values in patients with coronary artery disease (CAD). Methods and Results —Plasma levels of sPLA 2 were measured in 142 patients with CAD and in 93 control subjects by a radioimmunoassay. The sPLA 2 levels had a significant and positive relations with serum levels of C-reactive protein, a marker of systemic inflammation, and with the number of the traditional coronary risk factors associated with individuals. Multivariate logistic regression analysis showed that higher levels of sPLA 2 (>246 ng/dL; 75th percentile of sPLA 2 distribution in controls) were a significant and independent risk factor for the presence of CAD. In multivariate Cox hazard analysis, the higher levels of sPLA 2 were a significant predictor of developing coronary events (ie, coronary revascularization, myocardial infarction, coronary death) during a 2-year follow-up period in patients with CAD independent of other risk factors, including CRP levels, an established inflammatory predictor. Conclusions —The increase in circulating levels of sPLA 2 is a significant risk factor for the presence of CAD and predicts clinical coronary events independent of other risk factors in patients with CAD; these results may reflect possible relation of sPLA 2 levels with inflammatory activity in atherosclerotic arteries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Cited by
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Macrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
Jung, U., & Choi, M.-S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046184 · Cited by 1,880
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Dennis, E. A., Cao, J., Hsu, Y.-H., Magrioti, V., & Kokotos, G. (2011) · Chemical Reviews · doi:10.1021/cr200085w · Cited by 1,203
Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart Disease
Packard, C. J., O'Reilly, D. S. J., Caslake, M. J., McMahon, A. D., Ford, I., Cooney, J., Macphee, C. H., Suckling, K. E., Krishna, M., Wilkinson, F. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431603 · Cited by 823
Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features
Iacobellis, G., & Bianco, A. C. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.07.003 · Cited by 599
Biochemistry and Physiology of Mammalian Secreted Phospholipases A2
Lambeau, G., & Gelb, M. H. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.062405.154007 · Cited by 513
Recent progress in phospholipase A2 research: From cells to animals to humans
Murakami, M., Taketomi, Y., Miki, Y., Sato, H., Hirabayashi, T., & Yamamoto, K. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.12.001 · Cited by 507
Dyslipidemia and inflammation: an evolutionary conserved mechanism
Esteve, E., Ricart, W., & Fernández-Real, J. M. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2004.08.004 · Cited by 492
Biomarkers of Atherosclerotic Plaque Instability and Rupture
Koenig, W., & Khuseyinova, N. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000251503.35795.4f · Cited by 418
Soppert, J., Lehrke, M., Marx, N., Jankowski, J., & Noels, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.019 · Cited by 407
Candidate‐based proteomics in the search for biomarkers of cardiovascular disease
Anderson, L. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.080473 · Cited by 378
OLOFSSON, S. ‐., & BORÈN, J. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01556.x · Cited by 330
Enzymatic toxins from snake venom: structural characterization and mechanism of catalysis
Kang, T. S., Georgieva, D., Genov, N., Murakami, M. T., Sinha, M., Kumar, R. P., Kaur, P., Kumar, S., Dey, S., Sharma, S., et al. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08115.x · Cited by 315
Tselepis, A. D., & John Chapman, M. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)00045-4 · Cited by 314
Leinonen, E., Hurt-Camejo, E., Wiklund, O., Hultén, L. M., Hiukka, A., & Taskinen, M.-R. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00371-4 · Cited by 274
Inflammatory Markers of Coronary Risk
Rader, D. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431609 · Cited by 260
A new era of secreted phospholipase A2
Murakami, M., Sato, H., Miki, Y., Yamamoto, K., & Taketomi, Y. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r058123 · Cited by 227
Gabay, C., McInnes, I. B., Kavanaugh, A., Tuckwell, K., Klearman, M., Pulley, J., & Sattar, N. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207872 · Cited by 140
Blache, D., Devaux, S., Joubert, O., Loreau, N., Schneider, M., Durand, P., Prost, M., Gaume, V., Adrian, M., Laurant, P., et al. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.04.008 · Cited by 105
Mechanism of lipoprotein retention by the extracellular matrix
Gustafsson, M., & Borén, J. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200410000-00003 · Cited by 75
Metadata
- Authors
- Kugiyama, K., Ota, Y., Takazoe, K., Moriyama, Y., Kawano, H., Miyao, Y., Sakamoto, T., Soejima, H., Ogawa, H., Doi, H., Sugiyama, S., & Yasue, H.
- Venue
- Circulation
- Published
- 1999-09-21
- Volume
- 100
- Issue
- 12
- Pages
- 1280-1284
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2170582496
- Cited by
- 249
- References
- 2
- FWCI
- 10.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.